Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
LyondellBasell Industries NV
NYSE:LYB
|
UK |
|
G
|
Groep Brussel Lambert NV
OTC:GBLBF
|
BE |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
InPlay Oil Corp
TSX:IPO
|
CA |
|
Buckle Inc
NYSE:BKE
|
US |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
V
|
Visteon Corp
XBER:VS51
|
US |
Wall St Price Targets
REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for REC is 59.21 EUR with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REC's stock price target?
Price Target
59.21
EUR
According to Wall Street analysts, the average 1-year price target for REC is 59.21 EUR with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 15%.
